Sawtooth Solutions, LLC Alaunos Therapeutics, Inc. Transaction History

Sawtooth Solutions, LLC

  • $3.64 Billion
  • Q4 2023

A detailed history of Sawtooth Solutions, LLC transactions in Alaunos Therapeutics, Inc. stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 14,250 shares of TCRT stock, worth $27,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,250
Previous 14,250 -0.0%
Holding current value
$27,930
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023
SELL
$0.12 - $0.5 $32 - $134
-269 Reduced 1.85%
14,250 $1,000
Q2 2023

Jul 26, 2023
BUY
$0.43 - $0.65 $401 - $606
933 Added 6.87%
14,519 $7,000
Q1 2023

Apr 27, 2023
BUY
$0.46 - $0.81 $6,249 - $11,004
13,586 New
13,586 $8,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $424M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email